Insmed Inc. buy Wells Fargo & Company
Start price
01.04.24
/
50%
€24.80
Target price
01.04.25
€51.22
Performance (%)
170.16%
End price
02.04.25
€67.00
Summary
This prediction ended on 02.04.25 with a price of €67.00. With a performance of 170.16% the BUY prediction by Wells_Fargo___Compan was a big success. Wells_Fargo___Compan has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | 10.236% | 10.236% | 104.380% |
| iShares Core DAX® | 1,60 % | -7,45 % | 3,04 % |
| iShares Nasdaq 100 | -0,73 % | -1,86 % | 15,42 % |
| iShares Nikkei 225® | 1,30 % | -6,80 % | 34,31 % |
| iShares S&P 500 | -0,39 % | -2,34 % | 9,91 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its "overweight" rating re-affirmed by analysts at Wells Fargo & Company. They now have a $55.00 price target on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten